Comparative reverse transcription-polymerase chain reaction and in situ hybridization analyses of human imprinted p57(KIP2) and insulin-like growth factor 2 gene transcripts in fetal kidney and Wilms' tumors using archival tissue

Laboratory Investigation

Volumn 78, Issue 1, 1998, Pages 19-28

  Soejima, Hidenobu ^a   McLay, Janet ^a   Hatada, Izuho ^b   Mukai, Tsunehiro ^b   Jinno, Yoshihiro ^c   Niikawa, Norio ^c   Yun, Kankatsu ^a,d  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c NAGASAKI UNIVERSITY   (Japan)

^d UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; SOMATOMEDIN B;

ALLELE; ARTICLE; FETUS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; KIDNEY DEVELOPMENT; NEPHROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALLELES; CYCLIN-DEPENDENT KINASE INHIBITOR P57; ENZYME INHIBITORS; FETUS; GENES, WILMS TUMOR; HUMANS; IN SITU HYBRIDIZATION; INSULIN-LIKE GROWTH FACTOR II; KIDNEY; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0031930991     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Chung WY, Yuan L, Feng L, Hensle T, and Tycho B (1996). Chromosome 11p15.5 regional imprinting: Comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors. Hum Mol Genet 5:1101-1108.
2. Edelstein RA, Krane RJ, Babayan R, de las Morenas A, and Moreland RB (1995). A rapid and simple method for the detection of prostate-specific antigen mRNA in archival tissue specimens using a reverse transcription-polymerase chain reaction assay. Urology 45:597-603.
3. Giannoukakis N, Deal C, Paquette J, Goodyer CG, and Polychronakos C (1993). Parental genomic imprinting of the human IGF2 gene. Nat Genet 4:98-101.
4. KIP2 and its reduced expression in Wilms' tumors. Hum Mol Genet 5:783-788.
5. KIP2 is mutated in Beckwith-Wiedemann syndrome. Nat Genet 14:171-173.
6. Iwamoto KS, Mizuno T, Ito T, Akiyama M, Takeichi N, Mabuchi K, and Seyama T (1996). Feasibility of using decades-old archival tissues in molecular oncology/ epidemiology. Am J Pathol 149:399-406.
7. Jeppesen P and Turner BM (1993). The inactive X chromosome in female mammals is distinguished by a lack of histone H4 acetylation, a cytogenetic marker for gene expression. Cell 74:281-289.
8. Jiang YH, Davidson LA, Lupton JR, and Chapkin RS (1995). A rapid RT-PCR method for detection of intact RNA in formalin-fixed paraffin-embedded tissues. Nucleic Acids Res 23:3071-3072.
9. Kitsberg D, Selig S, Brandeis M, Simon I, Keshet I, Driscoll DJ, Nicholls RD, and Cedar H (1993). Allele-specific replication timing of imprinted gene regions. Nature 364:459-463.
10. KIP2 gene at 11p15.5. Oncogene 12:1365-1368.
11. Koufos A, Grundy P, Morgan K, Aleck KA, Hadro T, Lampkin BC, Kalbakji A, and Cavenee WK (1989). Familial Beckwith-Wiedemann syndrome and a second Wilms' tumor locus both map to 11p15.5. Am J Hum Genet 44:711-719.
12. KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 9:639-649.
13. Leighton PA, Saam JR, Ingram RS, Stewart CL, and Tilghman SM (1995). An enhancer deletion affects both H19 and Igf2 expression. Genes Dev 9:2079-2089.
14. Little MH, Prosser J, Condie A, Smith PJ, Van Heyningen V, and Hastie ND (1992). Zinc finger point mutations within the WT1 gene in Wilms' tumor patients. Proc Natl Acad Sci USA 89:4791-4795.
15. Loh WE Jr, Scrable HJ, Livanos E, Arboleda MJ, Cavenee WK, Oshimuara M, and Weissmann BE (1992). Human chromosome 11 contains two different growth suppressor genes for embryonal rhabdomyosarcoma. Proc Natl Acad Sci USA 89:1755-1759.
16. CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9:650-662.
17. KIP2, on chromosome 11p15. Proc Natl Acad Sci USA 93:3026-3030.
18. Montagna M, Menin C, Chieco-Bianchi L, and D'Andrea E (1994). Occasional loss of constitutive heterozygosity at 11p15.5 and imprinting relaxation of the IGFII maternal allele in hepatoblastoma. J Cancer Res Clin Oncol 120:732-736.
19. Moulton T, Crenshaw T, Hao Y, Moosikasuwan J, Lin N, Dembitzer F, Hensle T, Weiss L, McMorrow L, Loew T, Kraus W, Gerald W, and Tycho B (1994). Epigenetic lesions at the H19 locus in Wilms' tumour patients. Nat Genet 7:440-447.
20. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, Maw MA, Smith PJ, and Reeve AE (1993). Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362:749-751.
21. Ohlsson R, Nyström A, Pfeifer-Ohlsson S, Töhönen V, Hedborg F, Schofield P, Flam F, and Ekström TJ (1993). IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome. Nat Genet 4:94-97.
22. KIP2 in soft tissue sarcomas and Wilms' tumors. Cancer Res 56: 1219-1221.
23. Pal N, Wadey RB, Buckle B, Yeomans E, Pritchard J, and Cowell JK (1990). Preferential loss of maternal alleles in sporadic Wilms' tumour. Oncogene 5:1665-1668.
24. Rainier S, Johnson LA, Dobry CJ, Ping AJ, Grundy PE, and Feinberg AP (1993). Relaxation of imprinted genes in human cancer. Nature 362:747-749.
25. KIP2 gene and its analysis in the G401 Wilms' tumor assay. Cancer Res 56:1214-1218.
26. Santos AC and Osorio-Almeida L (1993). Simultaneous extraction of RNA and DNA from paraffin-embedded tissues. Trends Genet 9:231.
27. Sasaki H, Jones PA, Chaillet JR, Ferguson-Smith AC, Barton S, Reik W, and Surani MA (1992). Parental imprinting: Potentially active chromatin of the repressed maternal allele of the mouse insulin-like growth factor II (Igf2) gene. Genes Dev 6:1843-1856.
28. Schroeder WT, Chao L, Dao DD, Strong LC, Pathak S, Riccardi V, Lewis WH, and Saunders GF (1987). Nonrandom loss of maternal chromosome 11 alleles in Wilms' tumor. Am J Hum Genet 40:413-420.
29. Scrable H, Cavenee W, Ghavimi F, Lovell M, Morgan K, and Sapienza C (1989). A model for embryonal rhabdomyosarcoma tumorigenesis that involves genomic imprinting. Proc Natl Acad Sci USA 86:7480-7484.
30. Seizinger B, Klinger HP, Junien C, Nakamura Y, Le Beau M, Cavenee W, Amanuel B, Ponder B, Naylar S, Mittleman F, Lois D, Menon A, Newsham I, Decker J, Kaelbling M, Henry I, and Deimling AV (1991). Report of the committee on chromosome and gene loss in human neoplasia. Cytogenet Cell Genet 58:1080-1096.
31. Steenman MJC, Rainier S, Dobry CJ, Grundy P, Horon IL, and Feinberg AP (1994). Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumour. Nat Genet 7:433-439.
32. Sugawara O, Takagi N, and Sasaki M (1985). Correlation between X-chromosome inactivation and cell differentiation in female preimplantation mouse embryos. Cytogenet Cell Genet 39:210-219.
33. Taniguchi T, Sullivan MJ, Ogawa O, and Reeve AE (1995). Epigenetic changes encompassing the IGF2/H19 locus associated with relaxation of IGF2 imprinting and silencing of H19 in Wilms' tumor. Proc Natl Acad Sci USA 92:2159-2163.
34. KIP2 in Wilms' tumor. Cancer Res 56:5723-5727.
35. Yun K, Fukumoto M, and Jinno Y (1996). Monoallelic expression of the insulin-like growth factor 2 gene in ovarian cancer. Am J Pathol 148:1081-1087.
36. Zhang Y and Tycho B (1992). Monoallelic expression of the human H79 gene. Nat Genet 1:40-44.
37. KIP2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387:151-158.